Form 4 holding
Director
SPECTRUM PHARMACEUTICALS INC
- Security class
- Common Stock, $0.001 par value
- Shares / value
- 64,277
- Estimated value
- $70,448
- Report date
- 17 Jun 2021
- Price
- $1.10
- Ownership
- Direct
Bernice R. Welles
Insider Reports History
- Reporting-owner location
- Henderson, NV
- Latest reporting-owner signature
-
/s/ Kurt A. Gustafson, attorney-in-fact for Bernice R. Welles
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Bernice R. Welles
Form 4 holding
Director
SPECTRUM PHARMACEUTICALS INC
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 67,804
- Estimated value
- Report date
- 17 Jun 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Bernice R. Welles
4
SPECTRUM PHARMACEUTICALS INC
- Report period
- 17 Jun 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 22 Jun 2021, 17:53
- Role
- Director
- Next action
- Open filing details